Journal of Medical Economics, Volume 5, Issue 1-4 (2002)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 5, Issue 1-4 (2002)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Volume 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Research Article

Article
Cost associated with venous thromboembolism treatment in the community
DJ Anderson, AD Burrell & A Bearne
Pages: 1-10
Published online: 02 Dec 2008
AbstractforCost associated with venous thromboembolism treatment in the community | References | PDF (94.2 KB)
  • 66 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost and effectiveness of ciprofloxacin + hydrocortisone versus neomycin + polymyxin B + hydrocortisone in France for the treatment of acute otitis externa
Antoine Lafuma MD, Francis Fagnani PhD & Gilles Berdeaux MD PhD
Pages: 11-23
Published online: 02 Dec 2008
AbstractforCost and effectiveness of ciprofloxacin + hydrocortisone versus neomycin + polymyxin B + hydrocortisone in France for the treatment of acute otitis externa | References | PDF (116.2 KB)
  • 109 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness analysis of proton pump inhibitors compared to omeprazole in the healing of reflux oesophagitis
Jonathan M Plumb & Steven J Edwards
Pages: 25-38
Published online: 02 Dec 2008
AbstractforCost-effectiveness analysis of proton pump inhibitors compared to omeprazole in the healing of reflux oesophagitis | References | PDF (490.7 KB)
  • 320 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article
Primary care workload in the management of chronic pain. A retrospective cohort study using a GP database to identify resource implications for UK primary care
Jonathan Belsey
Pages: 39-50
Published online: 02 Dec 2008
AbstractforPrimary care workload in the management of chronic pain. A retrospective cohort study using a GP database to identify resource implications for UK primary care | References | PDF (114.2 KB)
  • 420 Views
  • 38 CrossRef citations
  • 0Altmetric
Free Access
Article
Modelling the economic impact of recombinant activated Factor VII and activated prothrombin-complex concentrate in the treatment of a mild to moderate bleed in adults with inhibitors to clotting Factors VIII and IX at a comprehensive care centre in the UK
Isaac A O Odeyemi & Julian F Guest
Pages: 51-64
Published online: 02 Dec 2008
AbstractforModelling the economic impact of recombinant activated Factor VII and activated prothrombin-complex concentrate in the treatment of a mild to moderate bleed in adults with inhibitors to clotting Factors VIII and IX at a comprehensive care centre in the UK | References | PDF (438.6 KB)
  • 143 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost effectiveness of asthma treatment with a breath-actuated pressurised metered dose inhaler (BAI) - a prescribing claims study of 1856 patients using a traditional pressurised metered dose inhaler (MDI) or a breath-actuated device
Alan Haycox PhD, Gail Mitchell MBA, Christie Niziol BSc RGN & Richard Featherstone MBA
Pages: 66-77
Published online: 02 Dec 2008
AbstractforCost effectiveness of asthma treatment with a breath-actuated pressurised metered dose inhaler (BAI) - a prescribing claims study of 1856 patients using a traditional pressurised metered dose inhaler (MDI) or a breath-actuated device | References | PDF (109.6 KB)
  • 80 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article
The clinical and financial impact of oral triptans - an updated meta-analysis
J D Belsey
Pages: 79-89
Published online: 02 Dec 2008
AbstractforThe clinical and financial impact of oral triptans - an updated meta-analysis | References | PDF (508.6 KB)
  • 79 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article
Introduction of escitalopram, a new SSRI in Finland: comparison of cost-effectiveness between the other SSRIs and SNRI for the treatment of depression and estimation of the budgetary impact
Clément François, Harri Sintonen & Mondher Toumi
Pages: 91-107
Published online: 02 Dec 2008
AbstractforIntroduction of escitalopram, a new SSRI in Finland: comparison of cost-effectiveness between the other SSRIs and SNRI for the treatment of depression and estimation of the budgetary impact | References | PDF (153.3 KB)
  • 296 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access
Article
Factors associated with increased hospital costs in patients treated with lipid-based amphotericin B for empirical therapy
Richard N Greenberg MD, Pablo J Cagnoni MD, John R Wingard MD, Mary M Prendergast MBA & Kuo B Tong MS
Pages: 109-118
Published online: 02 Dec 2008
AbstractforFactors associated with increased hospital costs in patients treated with lipid-based amphotericin B for empirical therapy | References | PDF (128.9 KB)
  • 56 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access
Article
Modelling the economic impact of recombinant activated Factor VII compared to activated prothrombin-complex concentrate in the home treatment of a mild to moderate bleed in adults with inhibitors to clotting Factors VIII and IX in the UK
Isaac A O Odeyemi & Julian F Guest
Pages: 119-133
Published online: 02 Dec 2008
AbstractforModelling the economic impact of recombinant activated Factor VII compared to activated prothrombin-complex concentrate in the home treatment of a mild to moderate bleed in adults with inhibitors to clotting Factors VIII and IX in the UK | References | PDF (121 KB)
  • 126 Views
  • 26 CrossRef citations
  • 0Altmetric
Free Access
Article
A pharmacoeconomic evaluation of piperacillin/tazobactam versus meropenem in the treatment of adult febrile neutropenia
ETM Smyth, JG Barr, GM Hogg & BA Oppenheim
Pages: 135-145
Published online: 02 Dec 2008
AbstractforA pharmacoeconomic evaluation of piperacillin/tazobactam versus meropenem in the treatment of adult febrile neutropenia | References | PDF (85.7 KB)
  • 48 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Impact of Pseudomonas aeruginosa on resource utilization and costs in patients with exacerbated non-cystic fibrosis bronchiectasis
Meg Franklin et al.
Article | Published online: 27 Apr 2024
Open Access
Cost-effectiveness of rimegepant oral lyophilisate compared to best supportive care for the acute treatment of migraine in the UK
Karissa Johnston et al.
Article | Published online: 27 Apr 2024
Open Access
Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorder
Jeff Schein et al.
Article | Published online: 27 Apr 2024
Open Access
Value-based payment and financing for cell and gene therapies: challenges and potential solutions
James X. Zhang et al.
Editorial | Published online: 27 Apr 2024
Open Access
View all latest articles